Call Us Today! 880-2-57165371/79|info@beaconpharma.com.bd

shop

Home » shop
  • apalunix

    apalunix (Apalutamide INN)

    Product Description: BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with
    • Metastatic castration-sensitive prostate cancer
    • Non-metastatic castration resistant prostate cancer.
    Apalunix  works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells. Product Features:
    Product Name Apalunix
    Generic Name Apalutamide INN
    Formulation Tablet
    Available Pack Size 120's pot
    Available Strength 60 mg
    Registrations Available
    Website Apalunix.com
       
    Details
  • rebotix

    rebotix (Ribociclib)

    Product Description: Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:
    Product Name Ribotix
    Generic Name Ribociclib
    Formulation Tablet
    Available Pack Size 63's pot
    Available Strength 200 mg
    Registrations Available
       
    Details
  • Pembroxim 100mg

    pembroxim (Pembrolizumab)

    Product Description: Pembroxim, is found in injection form, under the generic of Pembrolizumab, to help patients fighting against the infection of certain types of cancer in the world. The medicine will be used in cancer immunotherapy that includes melanoma, head and neck cancer, Hodgkin lymphoma and stomach cancer. It is suggested for slow injection into vein of the patients. Product Features:
    Product Name Pembroxim
    Generic Name Pembrolizumab
    Formulation Injection
    Available Pack Size 1's Vial
    Available Strength 100 mg/4ml
    Registrations Available
       
    Details
  • nindanix 150 nindanix 100

    nindanix (nintedanib)

    Product Description: Nindanix is indicated for the treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) adenocarcinoma type in combination with docetaxel for the treatment of adult patients after the failure of first-line chemotherapy. Product Features:
    Product Name Nindanix
    Generic Name Nintedanib
    Formulation Capsule
    Available Pack Size 80 & 50 Capsule
    Available Strength 100 mg, 150 mg
    Registrations Available
       
    Details
  • niraparix niraparib

    niraparix (niraparib)

    Product Description: Niraparix is a once-daily, oral medicine used for the maintenance treatment of women with recurrent ovarian, fallopian tube, or primary peritoneal cancer when their cancer comes back. Niraparix is the first and only once-daily PARP inhibitor used after the cancer has responded (complete or partial response) to treatment with platinum-based chemotherapy Product Features:
    Product Name Niraparix
    Generic Name Niraparib
    Formulation Capsule
    Available Strength 100 mg
    Registrations Available
       
    Details
  • alecinix-150

    alecinix (alectinib)

    Product Description: Alectinib is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to Crizotinib. Alectinib as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). Product Features:
    Product Name Alecinix
    Generic Name Alectinib
    Formulation Capsule
    Available Strength 150 mg
    Registrations Available
    Website alecinix.com
       
    Details
  • nilonix 200 nilonix 150

    nilonix (nilotinib)

    Product Description: Nilotinib (Nilonix) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. Nilotinib is usually given after other medications have been tried without success. Product Features:
    Product Name Nilonix
    Generic Name Nilotinib
    Formulation Capsule
    Available Pack Size 120  Capsule
    Available Strength 150 mg, 200 mg
    Registrations Available
    Website: nilonix.com
       
    Details
  • briganix 180 briganix-90

    Briganix (brigatinib)

    Product Description: BRIGANIX is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Product Features:
    Product Name Briganix
    Generic Name Brigatinib
    Formulation Tablet
    Available Pack Size 30’s Pot
    Available Strength 90 mg, 180 mg
    Registrations Available
    Website: Briganix.com
       
    Details

  • Renesis (Roxadustat)

    Product Description: Renesis (Roxadustat) is a the first-in-class, oral tablet that promotes erythropoiesis through the endogenous production of erythropoietin (EPO) near physiological range. Upon administration, roxadustat binds to and inhibits HIF-PH (Prolyl Hyroxylase) , an enzyme responsible for the degradation of transcription factors in the HIF family under normal oxygen conditions. This prevents HIF breakdown and promotes HIF activity. Increased HIF activity leads to an increase in endogenous erythropoietin Production. It also upregulates the distribution, metabolism and absorption of iron within the body as well as downregulates hepcidin which is responsible for improper intracellular iron transportation. Therefore, Renesis (Roxadustat) can induce endogenous production of mature HB plump with iron. Renesis (Roxadustat) is indicated for treatment of adult patients with systematic anemia and functional iron deficiency anaemia associated with chronic kidney disease (CKD), Chemotherapy induced anemia and chronic disease induced anemia. Reneis (Roxadust) also improves hypo responsiveness of ESA in CKD patients. Product Features:
    Product Name Renesis
    Generic Name Roxadustat INN
    Formulation Oral Tablet
    Available Pack Size 3’s
    Available Strength 20 mg, 50 mg, 70mg & 100 mg
    Registrations Bangladesh
       
    Details
  • Ribociclib

    Ribotix (Ribociclib)

    Product Description: Ribociclib 200 mg  (Ribotix)  is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:
    Product Name Ribotix
    Generic Name Ribociclib
    Formulation Tablet
    Available Pack Size 63’s Pot
    Available Strength 200 mg
    Registrations Available
       
    Details
  • Enzalutamide enzalunix

    Enzalunix (Enzalutamide)

    Product Description: Enzalutamide (Enzalunix)  a non-steroidal anti-androgen medication that is used in the treatment of prostate cancer. Enzalunix is a hormonal therapy which is indicated for metastatic castration-sensitive prostate cancer (mCSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). Product Features:
    Product Name Enzalunix
    Generic Name Enzalutamide
    Formulation Tablet
    Available Pack Size 120’s Pot
    Available Strength 40 mg
    Registrations Available
       
    Details
  • Placeholder

    Xalcort (Deflazacort INN)

    Product Description:

    Xalcort is a preparation of Deflazacort INN which is an oxazolone derivative of prednisolone, possess similar effect like prednisolone but relatively fewer side effects than prednisolone. Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals, Deflazacort provides immunosuppressive action.

    Deflazacort is indicated for rheumatoid arthritis, juvenile chronic arthritis, asthma and other airway diseases, pemphigus, uveitis, nephrotic syndrome, immune suppression in transplantation, anaphylaxis, severe hypersensitivity reaction, dermatomyositis, mixed connective tissue disease, polyarteritis nodosa, bullous pemphigoid, ulcerative colitis, optic neuritis, autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura, acute and lymphatic leukemia and malignant lymphoma.

    Product Features:
    Product Name Xalcort
    Generic Name Deflazacort
    Formulation Tablet & Suspension
    Available Pack Size 6 mg (60’s), 24 mg (30’s), 30 mg (10’s), 50 mL & 30 mL
    Available Strength 6 mg, 24 mg, 30 mg Tablet & 6 mg per 5 mL Suspension
    Registrations Bangladesh
       
    Details
Toggle Sliding Bar Area